Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 236 results for "lupin ltd"

Lupin falls ahead of earnings

India's Lupin Q3 profit falls 12 pct, meets estimates

MUMBAI Feb 5 Lupin Ltd, India's third-largest drugmaker, reported a 12 percent fall in third-quarter profit that was in line with analysts' expectations. Net profit for the quarter ended Dec. 31 was 5.30 billion rupees ($78.3 million), down from ... Reuters India, 5 days ago
Lupin falls ahead of earnings Sify, 5 days ago
Lupin Q3 net profit likely to fall India Infoline, 6 days ago

3 images for "lupin ltd"

HT Syndication, 2 days ago
India Infoline, 5 days ago
First, 5 days ago
India Infoline

Lupin stock ends higher by 9%

Shares of pharmaceutical major Lupin Ltd recovered and ended the session higher by 9.04 per cent at Rs 1,801.45 on the BSE. Earlier, the stock plunged 2.8 per cent ahead of October-December quarter earnings. The results were expected during market hours.
 Business Line5 days ago Lupin ends in red despite FDA nod for chewable contraceptive  India Infoline1 month ago Lupin gets FDA nod for Generic Generess tablets  India Infoline1 month ago Lupin gets USFDA nod for generic Generess tablets  HT Syndication1 month ago


Lupin Ltd expects to obtain 25 product approvals from the US Food and Drug Administration (FDA) in 2015-2016. The company has reported a net profit of Rs529 crore for Oct-Dec 2015 (Rs601 crore for Oct-Dec 2014). Its total revenue has gone up to ...
 Pharmacy Choice2 days ago LUPIN : Sun Pharma and Lupin get tentative USFDA nod for schizophrenia drug  4 Traders2 weeks ago 1/27/16 - Sun Pharma and Lupin get tentative USFDA nod for schizophrenia drug [India Infoline News Service]  Pharmacy Choice2 weeks ago Sun Pharma and Lupin get tentative USFDA nod for schizophrenia drug [India Infoline News Service]  Pharmacy Choice2 weeks ago

Lupin's US growth picks up in Q3

The past few quarters had seen Lupin's results disappoint, particularly on sales growth in the US. This quarter did not The sharp decline in Lupin Ltd's share price since January appears to have set the stage for a smart recovery post-results. The ...
 Livemint.com2 days ago

Lupin launches generic diabetes drug in the US

NEW DELHI: Drug firm Lupin has launched its Metformin HCl tablets, a diabetes drug, in the US market and is eligible for 180 days exclusivity for the product. "The company's US subsidiary Lupin Pharmaceuticals Inc has launched its Metformin HCl ...
 Economic Times1 week ago

Aurobindo plans major push into oncology space [Mint, New Delhi]

Feb. 09--HYDERABAD -- Aurobindo Pharma Ltd is planning a major push to launch high-margin anti-cancer and hormone drugs, targeting a revenue of $3 billion in the next two years. In a recent investor presentation, the company said it is working on ...
 Bloomberg1 day ago

Lupin Pharmaceuticals v. Senju Pharm: Review Instituted and Joinder Granted IPR2015-01871

Takeaway: If a patent owner is opposing joinder, it needs to show how it will be unduly burdened by the joinder. In its Decision , the Board granted inter partes review of challenged claims 1-22 of the 431 Patent and granted joinder with ...
 National Law Review6 days ago

Infosys, TCS Lead Sensex Retreat as Global Selloff Deepens

(Bloomberg) -- Indian stocks declined for a second day and the currency weakened as renewed concern about the health of the global economy sparked a worldwide selloff. Tata Consultancy Services Ltd. and Infosys Ltd., the nation's largest software ...
 La Repubblica1 day ago

India stocks lower at close of trade; Nifty 50 down 1.21%

India stocks were lower after the close on Tuesday, as losses in the IT, Technology and Metals sectors led shares lower. At the close in NSE, the Nifty 50 fell 1.21%, while the BSE Sensex 30 index fell 1.10%. The best performers of the session ...
 Investing.com1 day ago India stocks higher at close of trade; Nifty 50 up 1.15%  Investing.com5 days ago

Japan Takes Aim at Ballooning Drug Prices as Costs Strain Budget

When two of the world's biggest pharmaceutical companies announced a tie-up in Japan, the country's $78 billion drug industry took note. In November, the country's largest drugmaker, Takeda Pharmaceutical Co., said itd separate its off-patent ...
 Bloomberg3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less